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Role of Novel Rat-specific Fc Receptor in Macrophage
Activation Associated with Crescentic Glomerulonephritis*
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Background: Fc receptor-mediated macrophage activation is a major cause of glomerular damage in crescentic
glomerulonephritis.
Results:We investigated the role of a novel rat Fc receptor, Fcgr3-rs, in human and rat macrophage activation.
Conclusion:We showed that this receptor prevents the cell signaling of its paralogue (Fcgr3).
Significance: These results provide a novel way to inhibit Fc receptor-mediated cell activation in macrophages.
Crescentic glomerulonephritis (Crgn) is a complex disease
where the initial insult is often the glomerular deposition of
antibodies against intrinsic or deposited antigens in the glo-
merulus. The role of Fc receptors in the induction andprogression
of Crgn is increasingly recognized, and our previous studies have
shown that copy number variation in Fcgr3 partially explains the
genetic susceptibility of the Wistar-Kyoto (WKY) rat to nephro-
toxic nephritis, a rat model of Crgn. The Fcgr3-related sequence
(Fcgr3-rs) is a novel rat-specific Fc receptor with a cytoplasmic
domain 6 amino acids longer than its paralogue, Fcgr3. The
Fcgr3-rs gene is deleted from theWKY rat genome, and this dele-
tion is associatedwith enhancedmacrophage activity in this strain.
Here, we investigated the mechanism by which the deletion of
Fcgr3-rs in theWKY strain leads to increasedmacrophage activa-
tion. By lentivirus-mediated gene delivery, we generated stably
transducedU937 cells expressing either Fcgr3-rs or Fcgr3. In these
cells, which lack endogenous Fcgr3 receptors, we show that
Fcgr3-rs interacts with the common Fc- chain but that Fc recep-
tor-mediated phagocytosis and signaling are defective. Further-
more, in primary macrophages, expression of Fcgr3-rs inhibits Fc
receptor-mediated functions, becauseWKYbonemarrow-derived
macrophages transduced with Fcgr3-rs had significantly reduced
phagocytic activity. This inhibitory effect on phagocytosis was
mediated by the novel cytoplasmic domain of Fcgr3-rs. These
results suggest thatFcgr3-rsmayact to inhibit Fcgr3-mediated sig-
naling and phagocytosis and could be considered as a novelmech-
anism in themodulation of Fc receptor-mediated cell activation in
autoimmune diseases.
In crescentic glomerulonephritis, leukocytes, especially
monocytes/macrophages, infiltrating the glomerulus play a
critical role in the development of the disease by recognizing
immunoglobulins and complement factors via cell surface
receptors (1). One of the checkpoints regulating the immune
response in glomerular inflammation is through leukocyte cell
surface receptors for the Fc (fragment crystallizable) portion of
IgG. The family of Fc receptors can regulate the fine balance
between pro-inflammatory versus anti-inflammatory states of
cell activation, and there is increasing evidence suggesting that
genetic susceptibility to autoimmune diseases is partly depen-
dent on Fc receptor-mediated activating and inhibitory signal-
ing pathways determining the net signal (pro- or anti-inflam-
matory) in the progression of the disease (2, 3). In systemic
lupus erythematosus, aberrant expression or the presence of
allelic variants of FcRs with altered functionality have been
reported to contribute to the pathogenesis of the disease (4).
There are two distinct classes of Fc receptors: the activatory
and the inhibitory receptors.Most activatory receptors serve as
the ligand-binding component of a receptor that also includes a
signal transducing molecule containing an immunoreceptor
tyrosine-based activationmotif (ITAM)2 (5). Inmonocytes and
macrophages, this role is fulfilled by the common  chain. Sig-
naling via its ITAM motif triggers the activation of multiple
downstream signaling pathways including the activation of Src
and Syk kinases, calcium mobilization, and NF-B activation,
leading ultimately to cellular responses such as phagocytosis
and cytokine production. The importance of activatory Fc
receptors in glomerulonephritis has been shown using mice
engineered to lack the ITAM-bearing Fc receptor  chain. We
and others have shown that these mice are protected from glo-
merulonephritis induced by antibodies to glomerular basement
membrane (6–8). In contrast, the inhibitory Fc receptor
FcRIIB has an immunoreceptor tyrosine-based inhibitory
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motif and does not use the common  chain (3). Activatory and
inhibitory Fc receptors are often expressed on the same cell,
and when co-aggregated by IgG antibody, the net signal to the
cell depends on the sum total of the activator and inhibitor
signals, thus setting thresholds for effector cell responses (3).
In our previous studies of nephrotoxic nephritis (NTN), a
model of crescentic glomerulonephritis in the Wistar-Kyoto
(WKY) rat, we performed genome-wide linkage analysis for
glomerular crescents, macrophage infiltration, and proteinuria
in an F2 population derived from NTN-susceptible WKY and
NTN-resistant Lewis rats (9). Themost significant linkage (log-
arithm of odds 8) was obtained with a quantitative trait locus
mapping to chromosome 13 (Crgn1) accounting, respectively,
for 21.8, 16.7, and 12.9% of the genetic variance in crescent
formation, proteinuria, andmacrophage infiltration. Positional
cloning of Crgn1 led to the identification and functional char-
acterization of the Fcgr3-related sequence (Fcgr3-rs), a novel
rat-specific activatory Fc receptor arising from copy number
variation in the Fcgr3 gene (9). The genomic rearrangement in
the Fcgr3 gene is such that there is a duplication of exon 5 in the
NTN-resistant Lewis genomic DNA with the presence of a
shorter exon lacking a sequence of 226 bp in its 3-untranslated
region. This shorter exon 5 was deleted in the WKY genome,
suggesting a copy number variation in the Fcgr3 gene. Sequence
analysis of this shorter copy of exon 5 revealed deletion of a
single guanine nucleotide at position 129 (G129) in the coding
sequence of the cytoplasmic domain, resulting in a frameshift
and generating a novel cytoplasmic domain 6 amino acids lon-
ger than that encoded by Fcgr3. We designated this copy num-
ber variant Fcgr3-related sequence (Fcgr3-rs) and showed that
this novel variant is transcribed and translated in the Lewis
strain, whereas it is deleted from the WKY genome (9).
Given the increased macrophage activity and associated
NTN susceptibility in theWKY rat that lacks the Fcgr3-rs mol-
ecule, it is important to understand how the presence of this
molecule might be influencing macrophage activity. Thus, we
have studied the role of Fcgr3-rs in macrophage activation. We
first investigated whether the genomic duplication/deletion
event giving rise to Fcgr3-rs occurred during the derivation of
inbred Wistar-related colonies. We have then generated U937
cells stably expressing either Fcgr3 or Fcgr3-rs and have studied
the role of Fcgr3-rs inmacrophage activation both inU937 cells
and WKY bone marrow-derived macrophages (BMDMs)
transduced with Fcgr3-rs. Our results show that the absence of
Fcgr3-rs is not specific to the WKY strain but is widely distrib-
uted throughout the rat phylogenetic tree. Furthermore, in
both humanmonocyte cell lines and primary rat macrophages,
expression of Fcgr3-rs inhibits Fcgr3-mediated signaling and
phagocytosis, suggesting that the rat possesses a unique mech-
anism by which Fc receptor-mediated cell activation can be
modulated.
EXPERIMENTAL PROCEDURES
Animals—WKY (WKY/NCrl) rats were purchased from
Charles River. All of the procedures were performed in accord-
ance with the United KingdomAnimals (Scientific Procedures)
Act.
Reagents—RPMI 1640 containing 25 mM L-glutamine was
purchased from Biowhittaker (Berkshire, UK). FCS was from
PAA (Yeovil, UK) or Labtech (East Sussex, UK). All of the
growth media were supplemented with penicillin (100 units/
ml) and streptomycin (100 g/ml), supplied as a 100 sterile
solution from Biowhittaker. LPS was obtained from Sigma.
Antibodies were from Millipore (anti-Myc), Santa Cruz
(F(ab)2, anti-Syk, anti-CD16), GE Healthcare (HRP-conju-
gated antibodies for Western blot), or Upstate Biotech (anti-
chain). pCSGW vector was a gift from Richard Jenner (Univer-
sity College London, London, UK).
Fcgr3 Exon 5 Genotyping—Fcgr3 exon 5 genotype was deter-
mined by PCR and agarose gel electrophoresis by using primers
to amplify exon 5 genomicDNA from 134 laboratory rat strains
and substrains available in theNational BioResource project for
the rat in Japan. The primer sequence used is as follows:
5-GTCCCTAAATTCTGAATTTC-3 and 5-AAAGAAGT-
CACAGAAAGGAG-3.
Lentiviral Constructs—Fcgr3 and Fcgr3-rs were amplified
from Lewis spleen cDNA with forward primer 5-AAGCTTG-
CCACCATGACTTTGGAG-3 and reverse primer 5-TCTA-
GATTATTAGCCATACGATGGGAT-3. Clones were ream-
plified with forward primer 5-CGGAAGCTTGCCACCATG-
GAGCAGAAACTCATCTCTGAAGAGGATCTGACTTTG-
GAGACCCAGATGTTTCAG-3 and reverse primer 5-CCT-
TGAGCACCTGGATCCATGGGG-3 and recloned. Site-
directedmutagenesis was performed on the Fcgr3 construct for
G129 with primers 5-GAGAAATCTTCAAACCTCGGGG-
AGGACTGGAGGAAATCCC-3 (forward) and 5-GGGA-
TTTCCTCCAGTCCTCCCCGAGGTTTGAAGATTTCTC-3
(reverse). All  subunit constructs were cloned into the
pcDNA3.1/Hygro() expression vector (Invitrogen). For
inserting an N-terminal Myc tag into the Fcgr3 constructs, 1.0
g of the Fcgr3, Fcgr3-rs, and Fcgr3-G constructs were
amplified with forward primer 5-CGGAAGCTTGCCACCA-
TGGAGCAGAAACTCATCTCTGAAGAGGATCTGACTT-
TGGAGACCCAGATGTTTCAG-3 and reverse primer 5-
CCTTGAGCACCTGGATCCATGGGG-3. Constructs and
PCR products were cut with HindIII and BamHI and ligated to
each other. Lentivirus constructs were prepared as follows:
DNA was excised from pCDNA3.1 by digestion with HindIII/
XbaI, and blunt ends were created using Pfu DNA polymerase.
This was ligated into a SmaI cut pENTR4.3F. This “in house”
modified version of the pENTR4 gateway vector contains a
multiple cloning site downstream of a CMV promoter and
upstream of an internal ribosome entry sequence, which medi-
ates expression of an enhanced GFP sequence. Inserts in the
correct orientation were identified by diagnostic restriction
enzyme digests. Subsequent digestion of this vector with SalI
and NotI released a DNA “cassette” containing the “gene of
interest” internal ribosome entry sequence-EGP sequences.
This was then cloned into the pCSGW lentiviral transfer vector
(10) following removal of the vectors own GFP sequence.
Lentiviral Production and Titration—Transfer vector
(pCSGW), lentiviral mammalian expression vector (envelope,
pMD2.G), and packaging vector (psPAX2)weremixed at a ratio
of 4:3:1 and used to infect confluentmonolayers of 293T17 cells
by calcium phosphate precipitation. The mediumwas replaced
Rat Fcgr3-rs Inhibits FcR Signaling and Cytokine Production
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after 16 h. Media containing virus were collected after a subse-
quent 24 and 48 h of culture. Insoluble debris was removed by
centrifugation and sterilized by filtration through 0.2- filters.
This crude viral supernatant was stored at 80 °C until use.
Titers of viral preparations produced in this way were estab-
lished by infection of U937 cells as follows. Briefly, U937 cells
were mixed with varying dilutions of viral supernatant (typi-
cally 1/5 to 1/500) in the presence of 8 mg/ml polybrene
(hexadimethrine bromide; Sigma). The cells were “spinocu-
lated” by spinning at 2200 rpm for 2 h at 30 °C. After 72 h, the
percentage of GFP-positive cells (FITC channel) was deter-
mined by FACS analysis (using a LSRII FACS). The lowest dilu-
tion factorwithGFP score of20%was used to calculate viral
titer.
U937 Lentiviral Line Production—Human monoblastic leu-
kemiaU937 cellswere infectedwith lentivirus carrying the gene
of interest at a ratio of 1:1 (cells:virus) as described above. The
cells were then cultured overnight before removal of virus con-
taining media. Cell surface Myc-positive cells (Myc-Fcgr3 or
Myc-Fcgr3RS) were isolated by panning on 10-cm Petri dishes
coatedwith anti-Myc antibody (Millipore). Adherent cells were
expanded in culture and used in subsequent experiments. GFP-
positive cells expressing pCSGW (no surface Myc) were iso-
lated by cell sorting based on FITC fluorescence. Subsequent
analysis of cell lines by FACS analysis confirmed 90–100% of
cells to be FITC-positive.
FcR Stimulation—The cells were resuspended in ice-cold
serum-free RPMI and anti-Myc antibody (Millipore) added to a
final concentration of 130g/ml. After 60min of incubation on
ice, the cells were washed three times and resuspended in
serum free RPMI with 8 mg/ml goat anti-mouse IgGF(ab)2.
The cells were then incubated at 37 °C for the indicated times.
The reaction was stopped by the addition of gel sample buffer
(2% SDS, 10% glycerol, 0.5% -mercaptoethanol, 50 mM Tris,
pH 6.8).
Immunoprecipitations andWestern Blot Analysis—The cells
were lysed in ice-cold lysis buffer (25 mM Tris, pH 7.6, 150 mM
NaCl, 1 mM EDTA, 0.1% Triton X-100, pH 7.8, 1% digitonin),
containing protease inhibitor mixture (Sigma) with 1mMDTT,
10 mM NaF, 100 mM sodium orthovanadate). The nuclei and
cell debris were removed by centrifugation, and supernatants
were precleared with protein G-Sepharose. Myc-labeled pro-
teins were then precipitated with anti-Myc antibody (Milli-
pore) or isotype matched control antibody and protein G-Sep-
harose for 1.5 h. Immunoprecipitated complexes were washed
in lysis buffer and were resolved on 4–20% SDS-PAGE gels
(Criterion).
After electrotransfer on to nitrocellulose membrane, the
membranes were blocked in 2% BSA/TBS/Tween (0.05%) and
probed with the appropriate antibodies at 4 °C overnight fol-
lowed by HRP-conjugated secondary antibody. Blots were
developed using ECL (Amersham Biosciences).
ELISAs—At 24 h after stimulation, the supernatants were
harvested. The concentrations of TNF and IL-10 were deter-
mined by ELISA (PharMingen) according to the manufactur-
er’s instructions. Absorbance was read and analyzed at 450 nm
on a spectrophotometric ELISA plate reader (LabsystemsMul-
tiskan Biochromic) using the Ascent software program.
BMDM Preparation and Phagocytosis Assay—Femurs from
adultWKY rats were isolated and flushedwithHanks’ balanced
salt solution. Total BM-derived cells were plated and infected
with lentivirus carrying the gene of interest at a ratio of 5:1
(cells: virus). 48 h following the infection, the medium was
replaced with DMEM that contained 25 mM HEPES (Sigma),
25% L929 conditioned medium, 25% decomplemented FBS
(Biosera), penicillin (100 units/ml; Invitrogen), streptomycin
(100 g/ml; Invitrogen), and cultured for 5 days. These cells
were characterized asmacrophages by ED-1 staining. To assess
phagocytosis, latex polystyrene 6.0-m microspheres (50
beads/macrophage; Polysciences Inc.) were opsonized with
BSA-anti-BSA IgG (Sigma) and added to transduced WKY
macrophages cultured in 8-well glass chamber slides. Following
staining with Diff-Quick fix (Dade Behring), 200 macrophages
were counted to determine the number of beads ingested per
cell.
Expression Analysis by qRT-PCR—Stably transduced U937
cellswere differentiated inmacrophages after addingPMA(100
nM) for 48 h and stimulated with LPS (Sigma; 1 g/ml) for 3 h.
Total RNA was extracted using TRIzol (Invitrogen), and one-
step qRT-PCR was performed using 100 ng of total RNA and
Brilliant II SYBR Green QRT-PCR Master Mix Kit (Agilent)
with specific primers for Tnfa and IL1b1 in an ABI 7900
sequence detection system (Applied Biosystems, Warrington,
UK). In rat BMDMs, Fcgr3 levels relative to total Fcgr3 (Fcgr3
Fcgr3-rs) were assessed by selecting a forward primer where
Fcgr3 differs from Fcgr3-rs by two single nucleotide polymor-
phisms at the end of the 3-end. The selected primers
were Fcgr3-Forward: 5TCTAGTGTGGTTCCATGCCG-3
and Fcgr3-Reverse: 5-TGTCCTGTGGAGCCTTGTACT-3;
total Fcgr3 (Fcgr3Fcgr3-rs)-Forward: 5-CTCCAGAC-
CCCTCAACTGGT-3 and total Fcgr3 (Fcgr3Fcgr3-rs)-Re-
verse: 5-GCAGTAGTAGTTCCCACTGT-3.
Statistical Analysis—Statistical differences in mean values
were compared using one-way analysis of variance followed by
Dunnett’s multiple comparison post-test; p 0.05 was consid-
ered statistically significant.
RESULTS
The Phylogeny of Genomic Deletion of Fcgr3-rs in Laboratory
Rat—Exon 5 of Fcgr3-rs contains a deletion of a single guanine
nucleotide at position 129 (G129) in the coding sequence of
the cytoplasmic domain (9). When compared with Fcgr3, this
G129 variant results in a frameshift in the Fcgr3-rs coding
sequence and generates a novel cytoplasmic domain 6 amino
acids longer than that encoded by Fcgr3 that was not found in
any other species (Fig. 1). We have previously shown that
Fcgr3-rs was deleted from NTN-susceptible Kyoto-derived
strains (9), but to investigate the distribution of this deletion
throughout the rat genealogical tree, we carried out a phyloge-
netic tree analysis of 94 inbred laboratory strains and 40 of their
substrains (Fig. 2). The results show that the deletion ofFcgr3-rs
is widespread throughout the rat phylogeny (32 of 94 strains),
suggesting that the origin of the deletion event is earlier then
the derivation of these strains.We also investigated the relative
levels of Fcgr3 and Fcgr3-rs mRNA levels in Lewis rat BMDMs
by qRT-PCR and showed that although there is relatively
Rat Fcgr3-rs Inhibits FcR Signaling and Cytokine Production
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increased Fcgr3 expression when compared with Fcgr3-rs, LPS
stimulation did not change the relative levels of both receptors
(Table 1).
U937 Cells Expressing Either Fcgr3 or Fcgr3-rs: Surface
Expression and Interaction with  Chain—The U937 cell line
does not express any endogenous FcgRIIIA (11) and is therefore
an ideal tool for the analysis of FcgRIII receptors, allowing
direct functional comparison between the rat orthologues
Fcgr3 and Fcgr3-rs. Thus, to study the role of Fcgr3-rs inmacro-
phage activation, we generated U937 cells stably transduced
with lentivirus constructs expressing the protein of interest.
U937 cells were infected with either Myc-tagged Fcgr3 (Myc-
Fcgr3), Myc tagged-Fcgr3-rs (Myc-Fcgr3RS), or empty
(pCSGW) lentiviral vectors. All of the lentiviral vectors con-
tained GFP. Expression of Myc-Fcgr3 and Myc-Fcgr3-rs was
confirmed by fluorescence microscopy, detecting GFP cells
and also by a Myc Western blot on lysates from stably trans-
duced U937 cells (Fig. 3A).We then investigated whetherMyc-
Fcgr3 and Myc-Fcgr3-rs are expressed on the surface of U937
cells. Flow cytometry analysis using an anti-Myc-APC mouse
antibody (mAb) showed that both Myc-Fcgr3 and Myc-
Fcgr3-rs are expressed on the cell surface at similar levels in
these cells (Fig. 3B). Because Fcgr3 transport to and expression
at the cell surface is known to be dependent on its association
with the common  chain (12), these findings implied that both
the Fcgr3 and Fcgr3-rs molecules were associated with  chain
at the cell surface. Co-immunoprecipitation analysis of U937
cells expressing either Fcgr3 or Fcgr3-rs demonstrated that this
was indeed the case (Fig. 3C). Thus, although Fcgr3-rs has an
additional cytoplasmic domain 6 amino acids longer than its
paralogue Fcgr3, it binds the -chain on the surface of stably
transduced and PMA-differentiated U937 macrophages.
Fcgr3-rs-mediated Signaling and Phagocytosis in U937 Cells—
In most macrophage Fc receptor complexes (with the excep-
tion of FcgrII), the ITAM-containing common -chain is
necessary for downstream signaling (13, 14). Thus, the
dimeric -chain forms multichain complexes with the ligand
binding -chain of Fcgr3 to allow signal transduction (3).
This signaling starts with tyrosine phosphorylation of the
ITAMs by kinases of the SRC family (15, 16) and leads to the
recruitment and subsequent phosphorylation of the Syk
kinase, followed by the activation of various downstream
targets such as PI3K and NF-B. Subesquent changes in gene
expression led to the induction of inflammatory cytokines
such as TNF. We were therefore keen to understand
whether the Fcgr3-rs is able to transduce signals similar to
those described for Fcgr3. However, despite its interaction
with the -chain, cross-linking of Fcgr3-rs with anti-Myc
antibody does not lead to phosphorylation of Syk or the deg-
radation of IB (Fig. 4A). This was not the case for the U937
macrophages stably transduced with Fcgr3 (Fig. 4A).
Furthermore, Fc receptor-mediated TNF production and
IgG-opsonized bead phagocytosis were also significantly less in
U937 macrophages expressing Fcgr3-rs when compared with
U937 macrophages stably transduced with Fcgr3 (Fig. 4B).
Taken together, these results suggest that the rat-specific
Fcgr3-rs is unable to mediate the same intracellular signals as
the wild type receptor.
Fcgr3-rs-and TLR4-mediated TNF and IL-1 Expression
Levels—To test whether the relative reduction in TNF pro-
duction in U937 cells transduced with Myc-Fcgr3RS is specific
to receptor cross-linking, we have stimulated the stably trans-
duced PMA-differentiated U937 cells with LPS for 3 h and
measured TNF and IL-1 expression levels by qRT-PCR (Fig.
5). Although the results have confirmed the previously shown
up-regulation of these genes in U937 cells (17), there was no
significant difference in the up-regulation of TNF and IL-1
between U937Myc-Fcgr3 and U937Myc-Fcgr3RS, dem-
onstrating that the inability of these cells to produce TNF is
not an intrinsic property of these cells and is specific to Fcgr3
stimulation (Fig. 5).
The Role of the Novel Cytoplasmic Domain of Fcgr3-rs in Rat
and Human Macrophage Activation—To study the effect of
Fcgr3-rs on the phagocytic activity of primary WKY BMDMs
where other endogenous, FcRs (Fcgr3 and others) are
expressed, we transduced these cells with lentivirus encoding
either Myc-Fcgr3rs or Myc-Fcgr3 and used cells transduced
with the empty vector (pCSGW) as controls.
Because the Fcgr3-rs also contains a number of single-base pair
substitutions in its extracellular domain, we were also keen to
establishwhether thesemight explain the differences between the
related sequence and wild type Fcgr3 molecules, possibly as a
FIGURE1.Rat-specificFcgr3-rs is anovelFc receptorwithauniquecytoplasmicdomain6aminoacids longer thenFcgr3.Shown is a comparisonof amino
acid sequences of transmembrane and cytoplasmic domains of rat Fcgr3 and Fcgr3-rs, human Fcgr3, and FCGR3 in other species. Fcgr3-rs has lost the terminal
PQDK sequence (highlighted) that is highly conserved across species. *, amino acid prediction based on human FCGR3A using Ensembl Genome Browser.
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result of altered FcR binding. Thus, we also generated an addi-
tional lentiviral construct encoding a chimeric protein to specifi-
cally test the effect of the novel cytoplasmic domain of Fcgr3-rs on
Fc receptor-mediated phagocytosis. Fcgr3-G contains the wild
type Fcgr3 extracellular, transmembrane, and cytoplasmic
domainswith thepresence of the Fcgr3-rs-specific novel cytoplas-
mic domain (9) (Fig. 6A).
We first measured the expression of Fcgr3 by using primers
specific for the transmembrane domain, thereby allowing differ-
ential amplification between Fcgr3 and Fcgr3-rs transcripts (Fig.
6B).We thenmeasured the number of opsonized beads phagocy-
tosed by 200WKY BMDMs transduced with each different lenti-
viral construct.
Phagocytosis was significantly reduced in Fcgr3-rs transduced
WKY BMDMs when compared with those transduced with
pCSGW (Fig. 6C). This inhibitory effect is clearlymediated by the
novel cytoplasmic domain of Fcgr3-rs, because similar reductions
in phagocytic activity were seen in WKY BMDMs transduced
either with Fcgr3-G or with Fcgr3-rs (Fig. 6C). Taken together,
these data suggest that the presence of FcRs containing the related
sequence cytoplasmic domain is able to reduce phagocytosis
mediated by endogenous FcRs in theWKY BMDMs.
To further understand the mechanism of action of the
Fcgr3-rs, we then investigated how the Fcgr3 and Fcgr3-rs
FIGURE 2. Phylogenetic tree of 134 laboratory rat strains according to the presence or absence of Fcgr3-rs in the genome. A phylogenetic tree of 94
strains is shown. Strains having numerous substrains (i.e. SHR, F344) are shown in capital letters, and all of the substrains showed the same genotype as the
founder strain. The tree was developed through a heuristic search for maximum parsimony implemented in PAUP 4.0b10. TreeView was used to display the
radial tree. For BD IX, LEC/Tj, and WM/Tj, genotypes could not be determined.
TABLE 1
Relative mRNA levels of Fcgr3 and Fcgr3-rs in Lewis rat BMDMs
Expression was assessed by qRT-PCR with specific primers that differentiate
between Fcgr3 and Fcgr3-rs in basal and LPS-stimulated (100 ng/ml, for 5 h)
BMDMs. Fcgr3 and Fcgr3-rs expression levels were normalized to total Fcgr3
(Fcgr3 Fcgr3-rs) levels.
Expression
BMDM
Basal LPS
Fcgr3/(Fcgr3 Fcgr3-rs) 0.73 0.02 0.67 0.01
Fcgr3-rs/(Fcgr3 Fcgr3-rs) 0.27 0.02 0.33 0.01
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interact with TLR4-mediated TNF production following
LPS stimulation. U937 cells transduced with FcRs (U937 
Myc-Fcgr3, U937  MycFcgr3RS, and U937  Myc-
Fcgr3G) were cross-linked with anti-Myc antibodies and
IgG F(ab)2. Following washing, the cells were stimulated
with LPS for 5 h. TNF and IL-10 protein levels were meas-
ured by sandwich ELISA.
In the absence of any additional FcR expression in these
cells, treatment with AbFab complexes resulted in a 38%
decrease in TNF production. This was further decreased in
FIGURE 3. Surface expression of Fcgr3-rs and Fcgr3 and assessment of their interactionwith the chain in stably transducedU937 cells. A, illustration
of GFP expression in U937 pCSGWandU937Myc-Fcgr3 by fluorescentmicroscopy (40). Myc and-tubulin (loading control)Western blots of whole cell
lysates from stably transduced U937 cells are shown. B, the human monoblastic leukemia cell line U937 was stably transduced to express either Myc-Fcgr3
(U937Myc-Fcgr3) or Myc-Fcgr3RS (U937Myc-Fcgr3RS) lentiviral constructs co-expressing GFP together with transgene. Untransduced cells (U937) and
cells transduced with lentiviral construct expressing GFP alone (without any transgene, U937  pCSGW) were used as controls. Surface expression was
measured by using anti-Myc-APCmAb. All of the transduced cells were GFP as shown by FITC emission. C, stably transduced U937 cells were differentiated
into macrophages after adding PMA (100 nM) for 48 h, and cell lysates were precipitated with anti-Myc antibody. Immunoprecipitated proteins were blotted
with anti- chain antibody.
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the presence of the Fcgr3 molecule to 50% of that seen in
cells that are not cross-linked, revealing that signals from
Fcgr3 act to reduce TLR4-induced TNF production in U937
cells (Fig. 6D). In contrast, the presence of either the Fcgr3-rs
or Fcgr3G did not result in any changes in TNF produc-
tion compared with cells that are not cross-linked. Levels of
IL-10 produced in these cells did not differ significantly
between Fcgr3 and FcgR3-rs or FcgR3-G cells (Fig. 6E),
revealing that the Fcgr3-rs is not functioning in these cells by
increasing levels of this anti-inflammatory cytokine.
DISCUSSION
There is considerable evidence from experimental models of
crescentic glomerulonephritis that Fc receptors play a central
role in disease progression. In mice, the FcR chain-deficient
mice (FcR/) lack surface expression of both murine activa-
tor Fc receptors I, III, and IV, and the high affinity IgE receptor
(FcRI) (18). Several studies have shown that FcR/mice are
protected from disease in accelerated nephrotoxic nephritis (6,
7, 19), and we have shown that the disease is mediated by Fc
receptors on circulating leukocytes and not intrinsic renal cells
(8).Our previous studies in theNTNmodel in theWistarKyoto
rat showed that the disease architecture is complex and highly
heritable, with seven quantitative trait loci (Crgn1–7) linked to
the percentage of glomerular crescents and controlling mainly
macrophage activation through distinct transcriptome profiles
(9, 20–22). In this model, we showed that copy number varia-
tion in rat Fcgr3 locus led to the deletion of Fcgr3-rs in theWKY
rat, predisposing this strain to enhanced macrophage activity
(9).
The purpose of the current study was to understand the
mechanism by which the genomic deletion of Fcgr3-rs leads to
macrophage overactivation and whether the novel cytoplasmic
domain binds to the common  chain to trigger downstream
signaling pathways. We first investigated the distribution of
Fcgr3-rs deletion throughout the rat phylogeny and found that
the deletion was widespread. It was previously reported that
five outbred Wistar and one Long-Evans stocks have Fcgr3-rs
(23), suggesting that the deletion has originated from the ances-
tor outbredWistar colony in theWistar institute in the United
States.Wenowconfirmand extend these findings because all of
the laboratory rat strains that we genotyped for Fcgr3 copy
FIGURE 4. Fc receptor-mediated signaling andphagocytosis inU937 cells
stably transducedwithMyc-Fcgr3RS.A, Fc receptor stimulation after cross-
linking with anti-Myc Ab for a maximum of 20 min and analysis of Syk phos-
phorylation and IB degradation in stably transducedU937-derivedmacro-
phages. B, TNF levels were assessed by sandwich ELISA after cross-linking
stably transduced U937 macrophages by anti-Myc mAb. Supernatants were
collected after 48 h of incubation. Fc receptor-mediated bead phagocytosis
was assayed by incubating macrophages with IgG opsonized latex beads.
Nonopsonizedbeads did not showanyphagocytosis. *,p 0.001when com-
pared with U937Myc-Fcgr3.
FIGURE 5. Fcgr3-rs does not affect TLR4-mediated Tnfa and Il1b1 expressions in stably transduced U937 cells. Stably transduced U937 cells were
differentiated inmacrophages after adding PMA (100 nM) for 48 h and stimulatedwith LPS (1g/ml) for 3 h. Tnfa and Il1b1 gene expressionweremeasured by
qRT-PCR. ns, not significant.
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number variation are derived from outbred Wistar and Long-
Evans stocks.
Previously, to investigate how Fcgr3-rs exerts its inhibitory
effect on Fc receptor signaling, we have transfectedCOS7 cells
and have shown that although Fcgr3-rs is expressed on the cell
surface, it is less efficient than Fcgr3 in mediating phagocytosis
(9). It also had an inhibitory effect on Fcgr3-mediated phagocy-
tosis when both receptors were co-transfected in COS7 cells
FIGURE 6. Fcgr3-rs inhibits Fc receptor-mediated phagocytosis inWKY BMDMs. A, schematic representation of the functional differences between Fcgr3
and Fcgr3-rs. Although there are amino acid changes in the Fcgr3-rs extracellular, transmembrane, and cytoplasmic domains (indicated by bars) when
compared with Fcgr3, the major structural difference is the presence of a novel cytoplasmic domain. The chimeric Fcgr3-G has the extracellular transmem-
brane and cytoplasmic domains identical to Fcgr3, the only difference being the presence of the novel cytoplasmic domain. B, Fcgr3 expression was assessed
by qRT-PCR in stably transduced U937 cells by using specific primers designed based on polymorphisms in the transmembrane domain differentiating
between Fcgr3 and Fcgr3-rs. The expression of Myc-Fcgr3 G was also assessed and showed similar expression levels as Fcgr3. This is because Fcgr3 and
Fcgr3-G share the same sequence in the transmembrane domain. C, WKY bonemarrow-derived cells were transduced with lentiviral constructs co-express-
ing GFPwith either Myc-tagged Fcgr3-rs (Myc-Fcgr3RS) or Myc-taggedwild type Fcgr3 (Myc-Fcgr3) or Myc-tagged Fcgr3-G. The lentiviral construct express-
ing GFP alone (without any transgene) was used as control (pCSGW). The cells were then differentiated into BM-derived macrophages by culturing in DMEM
containing L929, and Fc receptor-mediated phagocytosis was performed. **, p 0.01; *, p 0.05; ns, not significant when compared with pCSGW. D and E,
LPS-induced TNF (D) and IL-10 (E) levels were assessed by sandwich ELISA after cross-linking stably transduced U937 macrophages by anti-Myc mAb and
F(ab)2. Following cross-linking, the cells werewashed, and supernatants were collected after 5 h of incubationwith LPS (1g/ml). TNF and IL-10 production
were expressed as a percentage of that produced in LPS-stimulated cells without FcR cross-linking (100% of cytokine production). **, p  0.001 when
compared with LPS-stimulated cells without FcR cross-linking (100% of cytokine production; histogram in gray)
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(9). However, the COS7 cells are not primarily phagocytic cells
and donot endogenously express the chain,making it difficult
to draw mechanistic conclusions concerning the role of
Fcgr3-rs in Fc receptor-mediated signaling and activation.Here
wehave examined the signaling function of Fcgr3-rs in a human
monocyte cell line U937, a well characterized cell line previ-
ously used to study Fc receptor function (11). U937 cells con-
stitutively express only Fcgr1 and Fcgr2a but not Fcgr3 (11).We
have used lentivirus-mediated gene transfer to generate stably
transduced U937 cell lines. Our results showed that Fcgr3-rs
associates with the common -chain in these cells, but Fc
receptor-mediated signaling and phagocytosis are defective.
Importantly, WKY BMDMs transduced with the Fcgr3-rs also
showed reduced bead phagocytosis, and this was mediated
through the rat-specific novel cytoplasmic domain.
It is well established that the transmembrane domain is
required for association with the  chain and consequently cell
surface expression of Fcgr3 (24). Because of the amino acid
changes between Fcgr3 and Fcgr3-rs in the transmembrane
domains, it could therefore be argued that the amino acid
changes simply prevented Fcgr3-rs expression. This, however,
was not the case, and in bothU937 cells and primary ratmacro-
phages, Fcgr3-rs was expressed at the cell surface at similar
levels to Fcgr3. The use of the G chimeric molecule, which
contains the extracellular and transmembrane domains of
Fcgr3 combined with the cytoplasmic domain of Fcgr3-rs, also
demonstrates that the differences seen between Fcgr3 and
Fcgr3-rs functions are mediated only by the novel cytoplasmic
domain of Fcgr3-rs and cannot be explained by pointmutations
in the extracellular domain of Fcgr3-rs, which might simply
have prevented Fc binding of IgG.
Themajority of signaling cascades emanating from the Fcgr3
receptor complex are thought to be derived from the chain via
its ITAM motifs. Thus, removal of the  chain cytoplasmic
domain or mutations of tyrosine residues within the ITAM
motifs affects intracellular Ca levels, PI3K activity and recep-
tor-induced phosphorylation events (25). In particular there is
compelling evidence that activation of Syk is essential for sub-
sequent events such as receptor-induced phagocytosis (26, 27).
However, the cytoplasmic tail of the Fcgr3 molecule is unlikely
to be completely redundant in this process, and Hou et al. (28)
have suggested that sequences within the cytoplasmic domain
of Fcgr3, in particular those close to the transmembrane
domain, are required for signaling. Our findings demonstrate
that signaling from the Fcgr3-rs is clearly different from that
mediated by Fcgr3, because Fcgr3-rs chain complexes do not
generate phosphorylated Syk molecules or activate the NF-B
transcription factor that is required for transcription of Fc-re-
sponsive genes such as TNF. Accordingly, IgG-inducedTNF
production and phagocytosis are both significantly lower in
U937 cells expressing Fcgr3-rs compared with Fcgr3. More-
over, expressing Fcgr3-rs in primary ratWKYBMDMs resulted
in lower levels of phagocytosis than cells expressing Fcgr3
alone, suggesting that Fcgr3-rs has an inhibitory effect on
Fcgr3-mediated phagocytosis in these cells.
Although the Fcgr3-rs cytoplasmic domain includes a novel
sequence with a single tyrosine molecule, this is not an immu-
noreceptor tyrosine-based inhibitory motif in the same way as
that found in the FcgrIIb receptor. Elegant studies by Kim et al.
(29) have shown that specific regions of the transmembrane
region of Fc receptors are important for signaling leading to
phagocytosis. The same group has provided further evidence
on differences in the signaling properties of FcR1/ and
FcRIIA such as their interactionwith Syk and Src-related tyro-
sine kinases (30). The region of the cytoplasmic domain shown
by Hou et al. (28) to be important in signaling is present in the
Fcgr3-rs; however, it is possible that the altered sequence of the
remainder of the cytoplasmic domain may render this region
inaccessible to essential downstream signaling molecules,
thereby rendering it inactive. The question of whether the
Fcgr3-rs exerts its effects by acting as a decoy receptor, binding
immunoglobulins, but not signaling, or whether its novel cyto-
plasmic domain induces distinct signaling pathways that act to
inhibit those from the wt Fcgr3 is therefore an interesting one.
Our demonstration herein that the -rs does not induce Syk or
NF-B activation suggests that this molecule may not signal,
and this is underscored by the demonstration that LPS-induced
TNF and IL-10 production is unaffected in U937 cells by the
presence of the -rs. Taken together, these data add further
weight to the argument that Fcgr3-rs is a decoy receptor that is
able to bind Fc but unable to signal such that its expression
inhibits co-expressed Fc receptor-mediated signaling and cell
activation. However, we cannot completely rule out a potential
additional role of this receptor, which will lead to inhibition by
a novel negative signaling pathway. Investigations into this
question are continuing in this laboratory.
In conclusion, our results suggest that the rat-specific
Fcgr3-rs acts to inhibit Fcgr3-mediated signaling and phagocy-
tosis in both rodent and human cells and could be considered as
a novel therapeutic mechanism for themodulation of Fc recep-
tor-mediated cell activation in macrophage-mediated diseases
such as crescentic glomerulonephritis.
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